Search Results

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Pharmaceutical development of nanostructured vesicular hydrogel formulations of rifampicin for wound healing by Wallenwein, Chantal (Author) , Weigel, Verena (Author) , Hofhaus, Götz (Author) , Dhakal, Namrata (Author) , Schatton, Wolfgang (Author) , Gelperina, Svetlana (Author) , Groeber-Becker, Florian K. (Author) , Dressman, Jennifer (Author) , Wacker, Matthias G. (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Early or deferred initiation of efavirenz during rifampicin-based TB therapy has no significant effect on CYP3A induction in TB-HIV infected patients by Aklillu, Eleni (Author) , Zumla, Alimuddin (Author) , Habtewold, Abiy (Author) , Amogne, Wondwossen (Author) , Makonnen, Eyasu (Author) , Yimer, Getnet (Author) , Burhenne, Jürgen (Author) , Diczfalusy, Ulf (Author) ,


    Get full text
    Article (Journal) Online Resource
  3. 3